News for Healthier Living

New Drug Candidate Reverses Metabolic Liver Disease and Fibrosis, Pre-Clinical Data Shows

Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita Therapeutics that has the potential to prevent and reverse liver fibrosis -- a dangerous, disease-induced build-up of scar tissue in the liver that often leads to cancer.

January 13, 2026


January 15 2026

January 14 2026

January 13 2026

January 12 2026

January 11 2026

January 10 2026

January 9 2026

January 8 2026

January 7 2026

January 6 2026

January 5 2026

January 4 2026

January 3 2026

January 2 2026

January 1 2026